par Piessens, Willy ;Lachapelle, Françoise F.L.;Legros, Nicole;Heuson, Jean-Claude
Référence Nature (London), 228, 5277, page (1210-1211)
Publication Publié, 1970
Article révisé par les pairs
Résumé : EXPERIMENTAL infections with "bacillus Calmette-Guérin" (BCG) have been shown to enhance the activity of the reticulo-endothelial system (RES) 1, to increase the formation of antibody against unrelated bacterial antigens2, to accelerate the rejection of normal tissue homografts3,4 and to enhance host resistance to grafted5-7 or primary induced5,8,9 animal tumours. Experimental leukaemia can be cured10 and remissions in human leukaemia prolonged with BCG treatment11. © 1970 Nature Publishing Group.